These authors proved that an e-nose system can differentiate VOC prints of COPD patients with AAT deficiency by obtaining a cross-validation value of 82% (with a sensitivity of 100% and a specificity of 100%) when exhaled breath condensates of AAT-deficiency and COPD groups were compared. The gene discussed is SERPINA1; the disease is chronic obstructive pulmonary disease.